Skip to main content
. 2022 Oct 25;32(6):1032–1047. doi: 10.1093/hmg/ddac262

Table 1.

Summary of variants identified by SNP microarray

Patient MRKH Type Clinical Phenotype CNV Size Location
MRKH01 II Uterovaginal agenesis; moderate renal impairment Duplication: 1q21.1
Deletion: 17q12
1.3 Mb
1.4 Mb
145 394 955–146 762 959
34 815 551–36 220 373
MRKH03 II Uterovaginal agenesis; unilateral renal agenesis Duplication: 3q13.12q13.13 0.4 Mb 107 822 130–108 214 218
MRKH06 I Uterine agenesis Duplication: 2q24.2 0.5 Mb 160 822 423–161 294 055
MRKH08 II Uterovaginal agenesis; fused vertebrae (C2–3), osteophytic foraminal narrowing (right C4–5, right C5–6, right C6–7). LCSH: Chr4 >5 Mb 140 586 701–145 900 002
MRKH10 II Uterovaginal agenesis; hearing impairment Deletion: Xp22.33
LCSH: Chr11
0.15 Mb
> 5 Mb
167 755–182 276
101 153 216–107 428 694